Second generation liposomal cancer therapeutics: Transition from laboratory to clinic

International Journal of Pharmaceutics

Volumn 448, Issue 1, 2013, Pages 28-43

  Sen, Kacoli ^a   Mandal, Mahitosh ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY   (India)

Author keywords

Cancer therapeutics; Drug delivery; Liposomes; Second generation

Indexed keywords

9 NITRO 20 CAMPTOTHECIN; ANNAMYCIN; BELOTECAN; CAMPTOTHECIN DERIVATIVE; CANFOSFAMIDE; CISPLATIN; CPX 1; CYTARABINE; DAUNORUBICIN; DOXORUBICIN; EMEPEPIMUT S; FIRTECAN; FLOXURIDINE; GADOLINIUM; IHL 305; INFLUENZA VACCINE; INX 0125; IRINOTECAN; IRINOTECAN PLUS FLOXURIDINE; LIPO DOX; LIPOPLATIN; LIPOSOME; LIPOXAL; LURTOTECAN; MBP 426; MITOPODOZIDE; MITOXANTRONE; NAVELBINE; NUCLEAR MAGNETIC RESONANCE IMAGING AGENT; OBLIMERSEN; OXALIPLATIN; PACLITAXEL; PEP 02; PLATINUM 1,2 DIAMINOCYCLOHEXANE BISNEODECANOATE; PNU 93914; RETINOIC ACID; THERMODOX; TOPOTECAN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VINCRISTINE SULFATE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADVANCED CANCER; ANTINEOPLASTIC ACTIVITY; B CELL LYMPHOMA; BIOCOMPATIBILITY; BIODEGRADABILITY; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER IMMUNIZATION; CANCER THERAPY; CHILDHOOD LEUKEMIA; COLON CANCER; COLORECTAL CANCER; DRUG CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG FORMULATION; DRUG PENETRATION; DRUG RETENTION; DRUG TARGETING; DRUG UPTAKE; ENDOMETRIUM CANCER; ENHANCED PERMEATION AND RETENTION; ESOPHAGUS CANCER; ESOPHAGUS METASTASIS; GENE DELIVERY SYSTEM; GLIOMA; HODGKIN DISEASE; HUMAN; HYPERTHERMIA; IMMUNOGENICITY; INFLUENZA; KAPOSI SARCOMA; LEUKEMIA; LIPID VESICLE; LIPOSOMAL DELIVERY; LIVER CELL CARCINOMA; LUNG CANCER; LUNG NON SMALL CELL CANCER; LUNG SMALL CELL CANCER; LYMPHOMA; LYMPHOMATOUS MENINGITIS; MALIGNANT MESOTHELIOMA; MELANOMA; MENINGITIS; MENTAL DISEASE; METASTASIS; MULTIDRUG RESISTANCE; NANOMEDICINE; NEPHROTOXICITY; NONHODGKIN LYMPHOMA; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; ORTHOSTATIC HYPOTENSION; OSMOTIC PRESSURE; OVARY CANCER; PANCREAS METASTASIS; PH; PRIORITY JOURNAL; RECURRENT CANCER; RETICULOENDOTHELIAL SYSTEM; REVIEW; SEIZURE; SENSORIMOTOR NEUROPATHY; SIDE EFFECT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SKIN TOXICITY; SOLID TUMOR; STOMACH TUMOR; SYSTEMIC CIRCULATION; TISSUE PRESSURE; TUMOR MICROENVIRONMENT; TUMOR RECURRENCE; UTERINE TUBE CARCINOMA; VASOPRESSIN RELEASE;

ANIMALS; ANTINEOPLASTIC AGENTS; DRUG DELIVERY SYSTEMS; HUMANS; LIPOSOMES; NEOPLASMS;

EID: 84875637379     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2013.03.006     Document Type: Review

References (257)

1. V. Agrawal, M.K. Paul, and A.K. Mukhopadhyay 6-mercaptopurine and daunorubicin double drug liposomes - preparation, drug-drug interaction and characterization J. Liposome Res. 15 2005 141 155 (Pubitemid 43062263)
2. Z.S. Al-Ahmady, W.T. Al-Jamal, J.V. Bossche, T.T. Bui, A.F. Drake, A.J. Mason, and K. Kostarelos Lipid-Peptide Vesicle Nanoscale Hybrids for Triggered Drug Release by Mild Hyperthermia in Vitro and in Vivo Acs. Nano. 6 10 2012 9335 9346
3. D.S. Alberts, F.M. Muggia, J. Carmichael, E.P. Winer, M. Jahanzeb, A.P. Venook, K.M. Skubitz, E. Rivera, J.A. Sparano, N.J. Dibella, S.J. Stewart, J.J. Kavanagh, and A.A. Gabizon Efficacy and safety of liposomal anthracyclines in phase I/II clinical trials Semin. Oncol. 31 2004 53 90 (Pubitemid 40023242)
4. T.M. Allen Ligand-targeted therapeutics in anticancer therapy Nat. Rev. Cancer 2 2002 750 763 (Pubitemid 37328910)
5. T.M. Allen, and P.R. Cullis Liposomal drug delivery systems: From concept to clinical applications Adv. Drug Deliv. Rev. 65 2012 36 48
6. T.M. Allen, C. Hansen, F. Martin, C. Redemann, and A. Yauyoung Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo Biochim. Biophys. Acta 1066 1991 29 36
7. J.D. Almeida, D.C. Edwards, C.M. Brand, and T.D. Heath Formation of virosomes from influenza subunits and liposomes Lancet 2 1975 899 901
8. S. Banerjee, T.K. Pal, and S.K. Guha Probing molecular interactions of poly(styrene-co-maleic acid) with lipid matrix models to interpret the therapeutic potential of the co-polymer Biochim. Biophys. Acta 1818 2012 537 550
9. S. Banerjee, K. Sen, T.K. Pal, and S.K. Guha Poly(styrene-co-maleic acid)-based pH-sensitive liposomes mediate cytosolic delivery of drugs for enhanced cancer chemotherapy Int. J. Pharm. 436 2012 786 797
10. A.D. Bangham, M.M. Standish, and J.C. Watkins Diffusion of univalent ions across the lamellae of swollen phospholipids J. Mol. Biol. 13 1965 238 252
11. A.D. Bangham, M.M. Standish, and G. Weissman Action of steroids and streptolysin S on permeability of phospholipid structures to cations J. Mol. Biol. 13 1965 253 259
12. Y. Barenholz Liposome application: problems and prospects Curr. Opin. Colloid Interface Sci. 6 2001 66 77 (Pubitemid 32233069)
13. Y. Barenholz Doxil (R) - The first FDA-approved nano-drug: Lessons learned J. Control. Release 160 2012 117 134
14. S.A. Barros, and J.A. Gollob Toxicity profile of RNAi nanomedicines Adv. Drug Deliv. Rev. 2012
15. G. Batist, G. Ramakrishnan, C.S. Rao, A. Chandrasekharan, J. Gutheil, T. Guthrie, P. Shah, A. Khojasteh, M.K. Nair, K. Hoelzer, K. Tkaczuk, Y.C. Park, L.W. Lee, and M.S. Grp Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized, multicenter trial of metastatic breast cancer J. Clin. Oncol. 19 2001 1444 1454 (Pubitemid 32202552)
16. N.C. Bellocq, S.H. Pun, G.S. Jensen, and M.E. Davis Transferrin- containing, cyclodextrin polymer-based particles for tumor-targeted gene delivery Bioconjug. Chem. 14 2003 1122 1132 (Pubitemid 37449039)
17. C.D.V. Black, and G. Gregoriadis Interaction of Liposomes with Blood-Plasma Proteins Biochem. Soc. Trans. 4 1976 253 256
18. G. Blume, and G. Cevc Molecular mechanism of the lipid vesicle longevity in vivo Biochim. Biophys. Acta 1146 1993 157 168 (Pubitemid 23084758)
19. L. Boehlke, and J.N. Winter Sphingomyelin/cholesterol liposomal vincristine: a new formulation for an old drug Expert. Opin. Biol. Ther. 6 2006 409 415
20. A.A. Bogdanov, C. Martin, R. Weissleder, and T.J. Brady Trapping of dextran-coated colloids in liposomes by transient binding to aminophospholipid - preparation of ferrosomes Bba Biomembr. 1193 1994 212 218 (Pubitemid 24234196)
21. N.L. Boman, V.A. Tron, M.B. Bally, and P.R. Cullis Vincristine-induced dermal toxicity is significantly reduced when the drug is given in liposomes Cancer Chemother. Pharmacol. 37 1996 351 355 (Pubitemid 26031013)
22. M. Bomsel, D. Tudor, A.S. Drillet, A. Alfsen, Y. Ganor, M.G. Roger, N. Mouz, M. Amacker, A. Chalifour, L. Diomede, G. Devillier, Z. Cong, Q.A. Wei, H. Gao, C.A. Qin, G.B. Yang, R. Zurbriggen, L. Lopalco, and S. Fleury Immunization with HIV-1 gp41 subunit virosomes induces mucosal antibodies protecting nonhuman primates against vaginal SHIV challenges Immunity 34 2011 269 280
23. G.D. Bothun, A. Lelis, Y. Chen, K. Scully, L.E. Anderson, and M.A. Stoner Multicomponent folate-targeted magnetoliposomes: design, characterization, and cellular uptake Nanomed. UK 7 2011 797 805
24. P.A. Bradbury, and F.A. Shepherd Immunotherapy for lung cancer J. Thorac. Oncol. 3 2008 S164 S170
25. E.N. Brody, and L. Gold Aptamers as therapeutic and diagnostic agents J. Biotechnol. 74 2000 5 13
26. J.W.M. Bulte, M. de Cuyper, D. Despres, and J.A. Frank Short- vs. long-circulating magnetoliposomes as bone marrow-seeking MR contrast agents J. Magn. Reson. Imaging 9 1999 329 335 (Pubitemid 29115361)
27. C. Butts, N. Murray, A. Maksymiuk, G. Goss, E. Marshall, D. Soulieres, Y. Cormier, P. Ellis, A. Price, R. Sawhney, M. Davis, J. Mansi, C. Smith, D. Vergidis, M. MacNeil, and M. Palmer Randomized phase IIB trial of BLP25 liposome vaccine in stage IIIB and IV non-small-cell lung cancer J. Clin. Oncol. 23 2005 6674 6681 (Pubitemid 46190262)
28. R. Cairns, I. Papandreou, and N. Denko Overcoming physiologic barriers to cancer treatment by molecularly targeting the tumor microenvironment Mol. Cancer Res. 4 2006 61 70
29. M. Calderon, M.A. Quadir, M. Strumia, and R. Haag Functional dendritic polymer architectures as stimuli-responsive nanocarriers Biochimie 92 2010 1242 1251
30. R.B. Campbell, B. Ying, G.M. Kuesters, and R. Hemphill Fighting cancer: from the bench to bedside using second generation cationic liposomal therapeutics J. Pharma. Sci. 98 2009 411 429
31. Cech, P.G.; Aebi, T.; Abdallah, M.S.; Mpina, M.; Machunda, E.B.; Westerfeld, N.; Stoffel, S.A.; Zurbriggen, R.; Pluschke, G.; Tanner, M.; Daubenberger, C.; Genton, B.; Abdulla, S.; 2011. Virosome-formulated Plasmodium falciparum AMA-1 & CSP derived peptides as malaria vaccine: randomized phase 1b trial in semi-immune adults & children. PloS One 6.
32. C.L. Chan, R.N. Majzoub, R.S. Shirazi, K.K. Ewert, Y.J. Chen, K.S. Liang, and C.R. Safinya Endosomal escape and transfection efficiency of PEGylated cationic liposome-DNA complexes prepared with an acid-labile PEG-lipid Biomaterials 33 2012 4928 4935
33. D.K. Chang, C.Y. Chiu, S.Y. Kuo, W.C. Lin, A. Lo, Y.P. Wang, P.C. Li, and H.C. Wu Antiangiogenic targeting liposomes increase therapeutic efficacy for solid tumors J. Biol. Chem. 284 2009 12905 12916
34. Chang, M.H.; Shau, W.Y.; Chen, C.J.; Wu, T.C.; Kong, M.S.; Liang, D.C.; Hsu, H.M.; Chen, H.L.; Hsu, H.Y.; Chen, D.S.; TCHS Group, 2000. Hepatitis B vaccination and hepatocellular carcinoma rates in boys and girls. J. Am. Med. Assoc. 284, 3040-3042.
35. G.N.C. Chiu, S.A. Abraham, L.M. Ickenstein, R. Ng, G. Karlsson, K. Edwards, E.K. Wasan, and M.B. Bally Encapsulation of doxorubicin into thermosensitive liposomes via complexation with the transition metal manganese J. Control. Release 104 2005 271 288 (Pubitemid 40724929)
36. S.J. Chiu, S. Liu, D. Perrotti, G. Marcucci, and R.J. Lee Efficient delivery of a Bcl-2-specific antisense oligodeoxyribonucleotide (G3139) via transferrin receptor-targeted liposomes J. Control. Release 112 2006 199 207
37. E.C. Cho, H.J. Lim, H.J. Kim, E.D. Son, H.J. Choi, J.H. Park, J.W. Kim, and J. Kim Role of pH-sensitive polymer-liposome complex in enhancing cellular uptake of biologically active drugs Mater. Sci. Eng. C Biol. Sci. 29 2009 774 778
38. K. Cho, X. Wang, S. Nie, Z.G. Chen, and D.M. Shin Therapeutic nanoparticles for drug delivery in cancer Clin. Cancer Res. 14 2008 1310 1316 (Pubitemid 351413909)
39. A. Chonn, P.R. Cullis, and D.V. Devine The role of surface-charge in the activation of the classical and alternative pathways of complement by liposomes J. Immunol. 146 1991 4234 4241
40. A. Chonn, S.C. Semple, and P.R. Cullis Beta 2 glycoprotein I is a major protein associated with very rapidly cleared liposomes in vivo, suggesting a significant role in the immune clearance of non-self particles J. Biol. Chem. 270 1995 25845 25849
41. Christensen, D.; Lindenstrom, T.; van de Wijdeven, G.; Andersen, P.; Agger, E.M.; 2010. Syringe free vaccination with CAF01 adjuvated Ag85B-ESAT-6 in bioneedles provides strong and prolonged protection against tuberculosis. PloS One 5.
42. R. Colomer What is the best schedule for administration of gemcitabine-taxane? Cancer Treat. Rev. 31 2005 S23 S28
43. C.R. Cooper, C.H. Chay, and K.J. Pienta The role of alpha(v)beta(3) in prostate cancer progression Neoplasia 4 2002 191 194 (Pubitemid 34525250)
44. D. Cosco, D. Paolino, F. Cilurzo, F. Casale, and M. Fresta Gemcitabine and tamoxifen-loaded liposomes as multidrug carriers for the treatment of breast cancer diseases Int. J. Pharm. 422 2012 229 237
45. W.R. Crom, S.S.N. Degraaf, T. Synold, D.R.A. Uges, H. Bloemhof, G. Rivera, M.L. Christensen, H. Mahmoud, and W.E. Evans Pharmacokinetics of vincristine in children and adolescents with acute lymphocytic-leukemia J. Pediatr. 125 1994 642 649 (Pubitemid 24318444)
46. E.T.M. Dams, P. Laverman, W.J.G. Oyen, G. Storm, G.L. Scherphof, J.W.M. Van der Meer, F.H.M. Corstens, and O.C. Boerman Accelerated blood clearance and altered biodistribution of repeated injections of sterically stabilized liposomes J. Pharmacol. Exp. Ther. 292 2000 1071 1079 (Pubitemid 30136603)
47. F. Danhier, A.L. Breton, and V. Preat RGD-based strategies to target alpha(v) beta(3) integrin in cancer therapy and diagnosis Mol. Pharma. 9 2012 2961 2973
48. F. Danhier, O. Feron, and V. Preat To exploit the tumor microenvironment: Passive and active tumor targeting of nanocarriers for anti-cancer drug delivery J. Control. Release 148 2010 135 146
49. M. de Smet, S. Langereis, S. van den Bosch, and H. Grull Temperature-sensitive liposomes for doxorubicin delivery under MRI guidance J. Control. Release 143 2010 120 127
50. S. Deok Kong, M. Sartor, C.M. Jack Hu, W. Zhang, L. Zhang, and S. Jin Magnetic field activated lipid-polymer hybrid nanoparticles for stimuli-responsive drug release Acta Biomater. 2012
51. J.S. Desgrosellier, and D.A. Cheresh Integrins in cancer: biological implications and therapeutic opportunities Nat. Rev. Cancer 10 2010 9 22
52. M.W. Dewhirst, L. Prosnitz, D. Thrall, D. Prescott, S. Clegg, C. Charles, J. MacFall, G. Rosner, T. Samulski, E. Gillette, and S. LaRue Hyperthermic treatment of malignant diseases: Current status and a view toward the future Semin. Oncol. 24 1997 616 625 (Pubitemid 28035878)
53. D. Di Paolo, M. Loi, F. Pastorino, C. Brignole, D. Marimpietri, P. Becherini, I. Caffa, A. Zorzoli, R. Longhi, C. Gagliani, C. Tacchetti, A. Corti, T.M. Allen, M. Ponzoni, and G. Pagnan Liposome-mediated therapy of neuroblastoma Methods Enzymol. 465 2009 225 249
54. B.M. Dicheva, T.L. Hagen, L. Li, D. Schipper, A.L. Seynhaeve, G.C. Rhoon, A.M. Eggermont, L.H. Lindner, and G.A. Koning Cationic thermosensitive liposomes: a novel dual targeted heat-triggered drug delivery approach for endothelial and tumor cells Nano Lett. 2012
55. A. Dicko, L.D. Mayer, and P.G. Tardi Use of nanoscale delivery systems to maintain synergistic drug ratios in vivo Exp. Opin. Drug Deliv. 7 2010 1329 1341
56. O. Diou, N. Tsapis, and E. Fattal Targeted nanotheranostics for personalized cancer therapy Exp. Opin. Drug Deliv. 9 2012 1475 1487
57. D.C. Drummond, O. Meyer, K.L. Hong, D.B. Kirpotin, and D. Papahadjopoulos Optimizing liposomes for delivery of chemotherapeutic agents to solid tumors Pharmacol. Rev. 51 1999 691 743
58. D.C. Drummond, C.O. Noble, Z.X. Guo, K. Hong, J.W. Park, and D.B. Kirpotin Development of a highly active nanoliposomal irinotecan using a novel intraliposomal stabilization strategy Cancer Res. 66 2006 3271 3277
59. D.C. Drummond, M. Zignani, and J.C. Leroux Current status of pH-sensitive liposomes in drug delivery Prog. Lipid Res. 39 2000 409 460
60. N. Duzgunes, and G. Gregoriadis Introduction: the origins of liposomes: Alec Bangham at Babraham Liposomes 391 Pt E 2005 1 3 (Pubitemid 40254026)
61. M.E. Eichhorn, S. Becker, S. Strieth, A. Werner, B. Sauer, M. Teifel, H. Ruhstorfer, U. Michaelis, J. Griebel, G. Brix, K.W. Jauch, and M. Dellian Paclitaxel encapsulated in cationic lipid complexes (MBT-0206) impairs functional tumor vascular properties as detected by dynamic contrast enhanced magnetic resonance imaging Cancer Biol. Ther. 5 2006 89 96 (Pubitemid 43234984)
62. D.J. Falcone Fluorescent opsonization assay - binding of plasma fibronectin to fibrin-derivatized fluorescent particles does not enhance their uptake by macrophages J. Leukoc. Biol. 39 1986 1 12 (Pubitemid 16212680)
63. D.J. Falcone Fluorescent opsonization assay: binding of plasma fibronectin to fibrin-derivatized fluorescent particles does not enhance their uptake by macrophages J. Leukoc. Biol. 39 1986 1 12 (Pubitemid 16212680)
64. N.P. Farrell Platinum formulations as anticancer drugs clinical and pre-clinical studies Curr. Top. Med. Chem. 11 2011 2623 2631
65. U. Fasol, A. Frost, M. Buchert, J. Arends, U. Fiedler, D. Schan, J. Scheuenpflug, and K. Mross Vascular and pharmacokinetic effects of EndoTAG-1 in patients with advanced cancer and liver metastasis Ann. Oncol. 23 2012 1030 1036
66. P.L. Felgner, and G.M. Ringold Cationic liposome-mediated transfection Nature 337 1989 387 388
67. E. Fleige, M.A. Quadir, and R. Haag Stimuli-responsive polymeric nanocarriers for the controlled transport of active compounds: Concepts and applications Adv. Drug Deliv. Rev. 64 2012 866 884
68. J. Floege, T. Ostendorf, U. Janssen, M. Burg, H.H. Radeke, C. Vargeese, S.C. Gill, L.S. Green, and N. Janjic Novel approach to specific growth factor inhibition in vivo - Antagonism of platelet-derived growth factor in glomerulonephritis by aptamers Am. J. Pathol. 154 1999 169 179 (Pubitemid 29031624)
69. A. Fomsgaard, I. Karlsson, G. Gram, C. Schou, S. Tang, P. Bang, I. Kromann, P. Andersen, and L.V. Andreasen Development and preclinical safety evaluation of a new therapeutic HIV-1 vaccine based on 18 T-cell minimal epitope peptides applying a novel cationic adjuvant CAF01 Vaccine 29 2011 7067 7074
70. E.A. Forssen, and Z.A. Tokes Use of anionic liposomes for the reduction of chronic doxorubicin-induced cardiotoxicity Proc. Natl. Acad. Sci. Biol. 78 1981 1873 1877 (Pubitemid 11114279)
71. A. Gabizon, A.T. Horowitz, D. Goren, D. Tzemach, F. Mandelbaum-Shavit, M.M. Qazen, and S. Zalipsky Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)-grafted liposomes: in vitro studies Bioconjug. Chem. 10 1999 289 298 (Pubitemid 29147733)
72. A. Gabizon, A.T. Horowitz, D. Goren, D. Tzemach, H. Shmeeda, and S. Zalipsky In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice Clin. Cancer Res. 9 2003 6551 6559 (Pubitemid 38031844)
73. S. Ganta, H. Devalapally, A. Shahiwala, and M. Amiji A review of stimuli-responsive nanocarriers for drug and gene delivery J. Control. Release 126 2008 187 204
74. K. Ghaghada, C. Hawley, K. Kawaji, A. Annapragada, and S. Mukundan T1 relaxivity of core-encapsulated gadolinium liposomal contrast agents - Effect of liposome size and internal gadolinium concentration Acad. Radiol. 15 2008 1259 1263
75. Ghaghada, K.B.; Ravoori, M.; Sabapathy, D.; Bankson, J.; Kundra, V.; Annapragada, A.; 2009. New dual mode gadolinium nanoparticle contrast agent for magnetic resonance imaging. PloS One 4.
76. R. Gluck, C. Moser, and I.C. Metcalfe Influenza virosomes as an efficient system for adjuvanted vaccine delivery Exp. Opin. Biol. Ther. 4 2004 1139 1145 (Pubitemid 38937555)
77. U. Gluck, J.O. Gebbers, and R. Gluck Phase 1 evaluation of intranasal virosomal influenza vaccine with and without Escherichia coli heat-labile toxin in adult volunteers J. Virol. 73 1999 7780 7786 (Pubitemid 29383262)
78. D. Goren, A.T. Horowitz, S. Zalipsky, M.C. Woodle, Y. Yarden, and A. Gabizon Targeting of stealth liposomes to erbB-2 (Her/2) receptor: in vitro and in vivo studies Br. J. Cancer 74 1996 1749 1756 (Pubitemid 26401894)
79. P. Goyal, K. Goyal, S.G. Vijaya Kumar, A. Singh, O.P. Katare, and D.N. Mishra Liposomal drug delivery systems - clinical applications Acta Pharm. 55 2005 1 25 (Pubitemid 40562616)
80. P. Goymer In the news - Gardasil - the perfect guard? Nat. Rev. Cancer 5 2005 840
81. Gram, G.J.; Karlsson, I.; Agger, E.M.; Andersen, P.; Fomsgaard, A.; 2009. A novel liposome-based adjuvant CAF01 for induction of CD8(+) Cytotoxic T-Lymphocytes (CTL) to HIV-1 Minimal CTL Peptides in HLA-A*0201 Transgenic Mice. PloS One 4.
82. G. Gregoria, E.J. Wills, C.P. Swain, and A.S. Tavill Drug-carrier potential of liposomes in cancer chemotherapy Lancet 1 1974 1313 1316
83. G. Gregoriadis Carrier potential of liposomes in biology and medicine New Engl. J. Med. 1 1976 704 710
84. H.H. Guan, W. Budzynski, R.R. Koganty, M.J. Krantz, M.A. Reddish, J.A. Rogers, B.M. Longenecker, and J. Samuel Liposomal formulations of synthetic MUC1 peptides: Effects of encapsulation versus surface display of peptides on immune responses Bioconjug. Chem. 9 1998 451 458 (Pubitemid 28338759)
85. B.J. Gurley Emerging Technologies for Improving Phytochemical Bioavailability: Benefits and Risks Clin. Pharmacol. Ther. 89 2011 915 919
86. I. Hamada, A.C. Hunter, J. Szebeni, and S.M. Moghimi Poly(ethylene glycol)s generate complement activation products in human serum through increased alternative pathway turnover and a MASP-2-dependent process Mol. Immunol. 46 2008 225 232
87. H. Hatakeyama, H. Akita, K. Maruyama, T. Suhara, and H. Harashima Factors governing the in vivo tissue uptake of transferrin-coupled polyethylene glycol liposomes in vivo Int. J. Pharm. 281 2004 25 33 (Pubitemid 39024260)
88. P. Hau, K. Fabel, U. Baumgart, P. Rummele, O. Grauer, A. Bock, C. Dietmaier, W. Dietmaier, J. Dietrich, C. Dudel, F. Hubner, T. Jauch, E. Drechsel, I. Kleiter, G. Wismeth, A. Zellner, A. Brawanski, A. Steinbrecher, J. Marienhagen, and U. Bogdahn Pegylated liposomal doxorubicin-efficacy in patients with recurrent high-grade glioma Cancer 100 2004 1199 1207 (Pubitemid 38325948)
89. T.D. Heath, J.A. Montgomery, J.R. Piper, and D. Papahadjopoulos Antibody-targeted liposomes: increase in specific toxicity of methotrexate-gamma-aspartate Proc. Natl. Acad. Sci. U. S. A. 80 1983 1377 1381 (Pubitemid 13082805)
90. V. Herbert, A.R. Larrabee, and J.M. Buchanan Studies on the identification of a folate compound of human serum J. Clin. Invest. 41 1962 1134 1138
91. C. Herzog, K. Hartmann, V. Kunzi, O. Kursteiner, R. Mischler, H. Lazar, and R. Gluck Eleven years of Inflexal (R) V-a virosomal adjuvanted influenza vaccine Vaccine 27 2009 4381 4387
92. R.D. Hofheinz, S.U. Gnad-Vogt, U. Beyer, and A. Hochhaus Liposomal encapsulated anti-cancer drugs Anti-Cancer Drug 16 2005 691 707 (Pubitemid 41104918)
93. H. Iinuma, K. Maruyama, K. Okinaga, K. Sasaki, T. Sekine, S. Ishida, N. Ogiwara, K. Johkura, and Y. Yonemura Intracellular targeting therapy of cisplatin-encapsulated transferrin-polyethylene glycol liposome on peritoneal dissemination of gastric cancer Int. J. Cancer 99 2002 130 137 (Pubitemid 34273210)
94. M.L. Immordino, F. Dosio, and L. Cattel Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential Int. J. Nanomed. 1 2006 297 315
95. O. Ishida, K. Maruyama, H. Tanahashi, M. Iwatsuru, K. Sasaki, M. Eriguchi, and H. Yanagie Liposomes bearing polyethyleneglycol-coupled transferrin with intracellular targeting property to the solid tumors in vivo Pharm. Res. Dordr. 18 2001 1042 1048 (Pubitemid 32799953)
96. T. Ishida, H. Harashima, and H. Kiwada Liposome clearance Biosci. Rep. 22 2002 197 224 (Pubitemid 35222732)
97. T. Ishida, D.L. Iden, and T.M. Allen A combinatorial approach to producing sterically stabilized (Stealth) immunoliposomal drugs FEBS Lett. 460 1999 129 133 (Pubitemid 29479257)
98. T. Ishida, M.J. Kirchmeier, E.H. Moase, S. Zalipsky, and T.M. Allen Targeted delivery and triggered release of liposomal doxorubicin enhances cytotoxicity against human B lymphoma cells Bba Biomembr. 1515 2001 144 158 (Pubitemid 33086831)
99. T. Ishida, K. Atobe, X.Y. Wang, and H. Kiwada Accelerated blood clearance of PEGylated liposomes upon repeated injections: Effect of doxorubicin- encapsulation and high-dose first injection J. Control Release 115 2006 251 258 (Pubitemid 44634849)
100. T. Ishida, M. Harada, X.Y. Wang, M. Ichihara, K. Irimura, and H. Kiwada Accelerated blood clearance of PEGylated liposomes following preceding liposome injection: Effects of lipid dose and PEG surface-density and chain length of the first-dose liposomes J. Control Release 105 2005 305 317 (Pubitemid 40941995)
101. T. Ishida, M. Ichihara, X. Wang, K. Yamamoto, J. Kimura, E. Majima, and H. Kiwada Injection of PEGylated liposomes in rats elicits PEG-specific IgM, which is responsible for rapid elimination of a second dose of PEGylated liposomes J. Control Release 112 2006 15 25
102. T. Ishida, T. Ichikawa, M. Ichihara, Y. Sadzuka, and H. Kiwada Effect of the physicochemical properties of initially injected liposomes on the clearance of subsequently injected PEGylated liposomes in mice J. Control Release 95 2004 403 412 (Pubitemid 38340491)
103. T. Ishida, R. Maeda, M. Ichihara, K. Irimura, and H. Kiwada Accelerated clearance of PEGylated liposomes in rats after repeated injections J. Control Release 88 2003 35 42 (Pubitemid 36173950)
104. T. Ishida, K. Masuda, T. Ichikawa, M. Ichihara, K. Irimura, and H. Kiwada Accelerated clearance of a second injection of PEGylated liposomes in mice Int. J. Pharm. 255 2003 167 174 (Pubitemid 36369600)
105. D.V. Jackson, E.H. Paschold, C.L. Spurr, H.B. Muss, F. Richards, M.R. Cooper, D.R. White, J.J. Stuart, J.O. Hopkins, R. Rich, and H.B. Wells Treatment of advanced non-hodgkins lymphoma with vincristine infusion Cancer 53 1984 2601 2606 (Pubitemid 14112886)
106. R.K. Jain Transport of molecules in the tumor interstitium - a review Cancer Res. 47 1987 3039 3051 (Pubitemid 17082621)
107. R.K. Jain Barriers to drug-delivery in solid tumors Sci. Am. 271 1994 58 65
108. R.K. Jain Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy Science 307 2005 58 62 (Pubitemid 40093472)
109. R.L. Juliano, and S.S. Daoud Liposomes as a delivery system for membrane-active antitumor drugs J. Control. Release 11 1990 225 232 (Pubitemid 20070100)
110. R.L. Juliano, and H.N. Mccullough Controlled delivery of an anti-tumor drug - localized action of liposome encapsulated cytosine-arabinoside administered via the respiratory system J. Pharmacol. Exp. Ther. 214 1980 381 387 (Pubitemid 10049051)
111. R.L. Juliano, and D. Stamp Lectin-mediated attachment of glycoprotein-bearing liposomes to cells Nature 261 1976 235 238
112. Kamphuis, T.; Meijerhof, T.; Stegmann, T.; Lederhofer, J.; Wilschut, J.; de Haan, A.; 2012. Immunogenicity and protective capacity of a virosomal respiratory syncytial virus vaccine adjuvanted with monophosphoryl lipid A in Mice. PloS One 7.
113. Y. Kaneda Virosomes: evolution of the liposome as a targeted drug delivery system Adv. Drug Deliv. Rev. 43 2000 197 205
114. T. Karino, S. Koga, and M. Maeta Experimental studies of the effects of local hyperthermia on blood-flow, oxygen-pressure and pH in tumors Jpn. J. Surg. 18 1988 276 283
115. D. Katsaros, M.V. Oletti, I.A.R. de la Longrais, A. Ferrero, A. Celano, S. Fracchioli, M. Donadio, R. Passera, L. Cattel, and C. Bumma Clinical and pharmacokinetic phase II study of pegylated liposomal doxorubicin and vinorelbine in heavily pretreated recurrent ovarian carcinoma Ann. Oncol. 16 2005 300 306 (Pubitemid 40309314)
116. C.Y. Ke, C.J. Mathias, and M.A. Green The folate receptor as a molecular target for tumor-selective radionuclide delivery Nucl. Med. Biol. 30 2003 811 817 (Pubitemid 38040989)
117. A.L. Klibanov, K. Maruyama, A.M. Beckerleg, V.P. Torchilin, and L. Huang Activity of amphipathic poly(ethylene glycol)-5000 to prolong the circulation time of liposomes depends on the liposome size and is unfavorable for immunoliposome binding to target Biochim. Biophys. Acta 1062 1991 142 148
118. A.L. Klibanov, K. Maruyama, V.P. Torchilin, and L. Huang Amphipathic polyethyleneglycols effectively prolong the circulation time of liposomes FEBS Lett. 268 1990 235 237 (Pubitemid 20233874)
119. H. Koide, T. Asai, K. Hatanaka, S. Akai, T. Ishii, E. Kenjo, T. Ishida, H. Kiwada, H. Tsukada, and N. Oku T cell-independent B cell response is responsible for ABC phenomenon induced by repeated injection of PEGylated liposomes Int. J. Pharm. 392 2010 218 223
120. G. Kong, G. Anyarambhatla, W.P. Petros, R.D. Braun, O.M. Colvin, D. Needham, and M.W. Dewhirst Efficacy of liposomes and hyperthermia in a human tumor xenograft model: Importance of triggered drug release Cancer Res. 60 2000 6950 6957 (Pubitemid 32059168)
121. G.A. Koning, A.M.M. Eggermont, L.H. Lindner, and T.L.M. ten Hagen Hyperthermia and thermosensitive liposomes for improved delivery of chemotherapeutic drugs to solid tumors Pharm. Res. Dordr. 27 2010 1750 1754
122. J. Kost, and R. Langer Responsive polymeric delivery systems Adv. Drug Deliv. Rev. 46 2001 125 148 (Pubitemid 33653418)
123. S.E. Krown, D.W. Northfelt, D. Osoba, and J.S. Stewart Use of liposomal anthracyclines in Kaposi's sarcoma Semin. Oncol. 31 2004 36 52 (Pubitemid 40023241)
124. P. Kulshrestha, M. Gogoi, D. Bahadur, and R. Banerjee In vitro application of paclitaxel loaded magnetoliposomes for combined chemotherapy and hyperthermia Colloid. Surf. B Biointerfaces 96 2012 1 7
125. S. Laurent, L.V. Elst, C. Thirifays, and R.N. Muller Paramagnetic liposomes: Inner versus outer membrane relaxivity of DPPC liposomes incorporating lipophilic gadolinium complexes Langmuir 24 2008 4347 4351 (Pubitemid 351569049)
126. C.P. Leamon, S.R. Cooper, and G.E. Hardee Folate-liposome-mediated antisense oligodeoxynucleotide targeting to cancer cells: Evaluation in vitro and in vivo Bioconjug. Chem. 14 2003 738 747 (Pubitemid 36875433)
127. R.J. Lee, and P.S. Low Delivery of liposomes into cultured Kb cells via folate receptor-mediated endocytosis J. Biol. Chem. 269 1994 3198 3204 (Pubitemid 24237629)
128. T.Y. Lee, C.T. Lin, S.Y. Kuo, D.K. Chang, and H.C. Wu Peptide-mediated targeting to tumor blood vessels of lung cancer for drug delivery Cancer Res. 67 2007 10958 10965
129. J.Y. Legendre, and F.C. Szoka Delivery of plasmid DNA into mammalian-cell lines using pH-sensitive liposomes - comparison with cationic liposomes Pharm. Res. Dordr. 9 1992 1235 1242
130. L. Li, T.L.M. ten Hagen, D. Schipper, T.M. Wijnberg, G.C. van Rhoon, A.M.M. Eggermont, L.H. Lindner, and G.A. Koning Triggered content release from optimized stealth thermosensitive liposomes using mild hyperthermia J. Control. Release 143 2010 274 279
131. S.H. Li, B. Goins, W.T. Phillips, M. Saenz, P.M. Otto, and A. Bao Post-lumpectomy intracavitary retention and lymph node targeting of Tc-99m-encapsulated liposomes in nude rats with breast cancer xenograft Breast Cancer Res. Tr. 130 2011 97 107
132. S.H. Li, B. Goins, L.J. Zhang, and A.D. Bao Novel multifunctional theranostic liposome drug delivery system: construction, characterization, and multimodality mr, near-infrared fluorescent, and nuclear imaging Bioconjug. Chem. 23 2012 1322 1332
133. X.M. Li, L.Y. Ding, Y.L. Xu, Y.L. Wang, and Q.N. Ping Targeted delivery of doxorubicin using stealth liposomes modified with transferrin Int. J. Pharm. 373 2009 116 123
134. T. Lian, and R.J.Y. Ho Trends and developments in liposome drug delivery systems J. Pharma. Sci. 90 2001 667 680 (Pubitemid 32530443)
135. T. Lindenstrom, E.M. Agger, K.S. Korsholm, P.A. Darrah, C. Aagaard, R.A. Seder, I. Rosenkrands, and P. Andersen Tuberculosis subunit vaccination provides long-term protective immunity characterized by multifunctional CD4 memory T Cells J. Immunol. 182 2009 8047 8055
136. L.H. Lindner, M.E. Eichhorn, H. Eibl, N. Teichert, M. Schmitt-Sody, R.D. Issels, and M. Dellian Novel temperature-sensitive liposomes with prolonged circulation time Clin. Cancer Res. 10 2004 2168 2178 (Pubitemid 38375579)
137. S.E. Lipshultz, S.R. Lipsitz, S.M. Mone, A.M. Goorin, S.E. Sallan, S.P. Sanders, E.J. Orav, R.D. Gelber, and S.D. Colan Female sex and higher drug dose as risk-factors for late cardiotoxic effects of doxorubicin therapy for childhood-cancer New Engl. J. Med. 332 1995 1738 1743
138. D.X. Liu, A. Mori, and L. Huang Large liposomes containing ganglioside Gm1 accumulate effectively in spleen Biochim. Biophys. Acta 1066 1991 159 165
139. P.L. Lollini, F. Cavallo, P. Nanni, and G. Forni Vaccines for tumour prevention Nat. Rev. Cancer 6 2006 204 216 (Pubitemid 43292564)
140. Y.J. Lu, and P.S. Low Folate-mediated delivery of macromolecular anticancer therapeutic agents Adv. Drug Deliv. Rev. 54 2002 675 693 (Pubitemid 35247522)
141. B. Ludewig, F. Barchiesi, M. Pericin, R.M. Zinkernagel, H. Hengartner, and R.A. Schwendener In vivo antigen loading and activation of dendritic cells via a liposomal peptide vaccine mediates protective antiviral and anti-tumour immunity Vaccine 19 2000 23 32 (Pubitemid 30618951)
142. A.N. Lukyanov, T.A. Elbayoumi, A.R. Chakilam, and V.P. Torchilin Tumor-targeted liposomes: doxorubicin-loaded long-circulating liposomes modified with anti-cancer antibody J. Control. Release 100 2004 135 144 (Pubitemid 39445991)
143. B.B. Lundberg, G. Griffiths, and H.J. Hansen Cellular association and cytotoxicity of anti-CD74-targeted lipid drug-carriers in B lymphorna cells J. Control Release 94 2004 155 161 (Pubitemid 37542385)
144. H. Maeda, and Y. Matsumura Tumoritropic and lymphotropic principles of macromolecular drugs Crit. Rev. Ther. Drug 6 1989 193 210 (Pubitemid 20065994)
145. Y. Malam, M. Loizidou, and A.M. Seifalian Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer Trends Pharmacol. Sci. 30 2009 592 599
146. R.W. Malone, P.L. Felgner, and I.M. Verma Cationic liposome-mediated RNA transfection Proc. Natl. Acad. Sci. U. S. A. 86 1989 6077 6081 (Pubitemid 19210605)
147. A.S. Manjappa, K.R. Chaudhari, M.P. Venkataraju, P. Dantuluri, B. Nanda, C. Sidda, K.K. Sawant, and R.S. Murthy Antibody derivatization and conjugation strategies: application in preparation of stealth immunoliposome to target chemotherapeutics to tumor J. Control. Release 150 2011 2 22
148. P. Marchisio, R. Cavagna, B. Maspes, S. Gironi, S. Esposito, L. Lambertini, A. Massimini, C. Herzog, and N. Principi Efficacy of intranasal virosomal influenza vaccine in the prevention of recurrent acute otitis media in children Clin. Infect. Dis. 35 2002 168 174 (Pubitemid 34753902)
149. E. Mastrobattista, G.A. Koning, and G. Storm Immunoliposomes for the targeted delivery of antitumor drugs Adv. Drug Deliv. Rev. 40 1999 103 127 (Pubitemid 29486607)
150. Y. Matsumura, M. Gotoh, K. Muro, Y. Yamada, K. Shirao, Y. Shimada, M. Okuwa, S. Matsumoto, Y. Miyata, H. Ohkura, K. Chin, S. Baba, T. Yama, A. Kannami, Y. Takamatsu, K. Ito, and K. Takahashi Phase I and pharmacokinetic study of MCC-465, a doxorubicin (DXR) encapsulated in PEG immunoliposome, in patients with metastatic stomach cancer Ann. Oncol. 15 2004 517 525 (Pubitemid 38444560)
151. L.D. Mayer, R. Krishna, M. Webb, and M. Bally Designing liposomal anticancer drug formulations for specific therapeutic applications J. Liposome Res. 10 2000 99 115
152. C.F. McDonagh, A. Huhalov, B.D. Harms, S. Adams, V. Paragas, S. Oyama, B. Zhang, L. Luus, R. Overland, S. Nguyen, J.M. Gu, N. Kohli, M. Wallace, M.J. Feldhaus, A.J. Kudla, B. Schoeberl, and U.B. Nielsen Antitumor activity of a novel bispecific antibody that targets the ErbB2/ErbB3 oncogenic unit and inhibits heregulin-induced activation of ErbB3 Mol. Cancer Ther. 11 2012 582 593
153. O.P. Medina, Y. Zhu, and K. Kairemo Targeted liposomal drug delivery in cancer Curr. Pharm. Design 10 2004 2981 2989 (Pubitemid 39214006)
154. J.M. Metselaar, P. Bruin, L.W.T. de Boer, T. de Vringer, C. Snel, C. Oussoren, M.H.M. Wauben, D.J.A. Crommelin, G. Storm, and W.E. Hennink A novel family of L-amino acid-based biodegradable polymer-lipid conjugates for the development of long-circulating liposomes with effective drug-targeting capacity Bioconjug. Chem. 14 2003 1156 1164 (Pubitemid 37449043)
155. G. Mikhaylov, U. Mikac, A.A. Magaeva, V.I. Itin, E.P. Naiden, I. Psakhye, L. Babes, T. Reinheckel, C. Peters, R. Zeiser, M. Bogyo, V. Turk, S.G. Psakhye, B. Turk, and O. Vasiljeva Ferri-liposomes as an MRI-visible drug-delivery system for targeting tumours and their microenvironment Nat. Nanotechnol. 6 2011 594 602
156. S.M. Moghimi Humoral-mediated recognition of 'phagocyte-resistant' beads by lymph node macrophages of poloxamine-treated rats Clin. Sci. 95 1998 389 391 (Pubitemid 28444850)
157. S.M. Moghimi, and S.S. Davis Innovations in avoiding particle clearance from blood by Kupffer cells - cause for reflection Crit. Rev. Ther. Drug 11 1994 31 59
158. S.M. Moghimi, and T. Gray A single dose of intravenously injected poloxamine-coated long-circulating particles triggers macrophage clearance of subsequent doses in rats Clin. Sci. 93 1997 371 379 (Pubitemid 27464301)
159. S.M. Moghimi, and J.C. Murray Poloxamer-188 revisited: A potentially valuable immune modulator J. Natl. Cancer I 88 1996 766 768 (Pubitemid 26195027)
160. S.M. Moghimi, and H.M. Patel Serum-mediated recognition of liposomes by phagocytic cells of the reticuloendothelial system - The concept of tissue specificity Adv. Drug Deliv. Rev. 32 1998 45 60 (Pubitemid 28277175)
161. C. Moser, I.C. Metcalfe, and J.F. Viret Virosomal adjuvanted antigen delivery systems Exp. Rev. Vac. 2 2003 189 196 (Pubitemid 36559924)
162. M.S. Mufamadi, V. Pillay, Y.E. Choonara, L.C. Du Toit, G. Modi, D. Naidoo, and V.M. Ndesendo A review on composite liposomal technologies for specialized drug delivery J. Drug Deliv. 2011 939851
163. F.M. Muggia, J.D. Hainsworth, S. Jeffers, P. Miller, S. Groshen, M. Tan, L. Roman, B. Uziely, L. Muderspach, A. Garcia, A. Burnett, F.A. Greco, C.P. Morrow, L.J. Paradiso, and L.J. Liang Phase II study of liposomal doxorubicin in refractory ovarian cancer: Antitumor activity and toxicity modification by liposomal encapsulation J. Clin. Oncol. 15 1997 987 993 (Pubitemid 27106281)
164. W.J.M. Mulder, G.J. Strijkers, A.W. Griffioen, L. van Bloois, G. Molema, G. Storm, G.A. Koning, and K. Nicolay A liposomal system for contrast-enhanced magnetic resonance imaging of molecular targets Bioconjug. Chem. 15 2004 799 806 (Pubitemid 38981954)
165. M. Murai, Y. Aramaki, and S. Tsuchiya Identification of the serum factor required for liposome-primed activation of mouse peritoneal-macrophages - modified alpha(2)-macroglobulin enhances Fc-gamma receptor-mediated phagocytosis of opsonized sheep red-blood-cells Immunology 86 1995 64 70
166. M.S. Muthu, S.A. Kulkarni, A. Raju, and S.S. Feng Theranostic liposomes of TPGS coating for targeted co-delivery of docetaxel and quantum dots Biomaterials 33 2012 3494 3501
167. K. Nakamura, A.S. Abu Lila, M. Matsunaga, Y. Doi, T. Ishida, and H. Kiwada A double-modulation strategy in cancer treatment with a chemotherapeutic agent and siRNA Mol. Ther. 19 2011 2040 2047
168. D. Needham, G. Anyarambhatla, G. Kong, and M.W. Dewhirst A new temperature-sensitive liposome for use with mild hyperthermia: Characterization and testing in a human tumor xenograft model Cancer Res. 60 2000 1197 1201 (Pubitemid 30151982)
169. E.D. Neerunjun, and G. Gregoriadis Tumor regression with liposome-entrapped asparaginase - some immunological advantages Biochem. Soc. Trans. 4 1976 133 134
170. A.H. Negussie, P.S. Yarmolenko, A. Partanen, A. Ranjan, G. Jacobs, D. Woods, H. Bryant, D. Thomasson, M.W. Dewhirst, B.J. Wood, and M.R. Dreher Formulation and characterisation of magnetic resonance imageable thermally sensitive liposomes for use with magnetic resonance-guided high intensity focused ultrasound Int. J. Hyperther. 27 2011 140 155
171. S. Neves, H. Faneca, S. Bertin, K. Konopka, N. Duzgunes, V. Pierrefite-Carle, S. Simoes, and M.C. Pedroso de Lima Transferrin lipoplex-mediated suicide gene therapy of oral squamous cell carcinoma in an immunocompetent murine model and mechanisms involved in the antitumoral response Cancer Gene Ther. 16 2009 91 101
172. C. Nicolazzi, N. Mignet, N. de la Figuera, M. Cadet, R.T. Ibad, J. Seguin, D. Scherman, and M. Bessodes Anionic polyethyleneglycol lipids added to cationic lipoplexes increase their plasmatic circulation time J. Control. Release 88 2003 429 443 (Pubitemid 36335802)
173. Okitsu, S.L.; Silvie, O.; Westerfeld, N.; Curcic, M.; Kammer, A.R.; Mueller, M.S.; Sauerwein, R.W.; Robinson, J.A.; Genton, B.; Mazier, D.; Zurbriggen, R.; Pluschke, G.; 2007. A virosomal malaria peptide vaccine elicits a long-lasting sporozoite-inhibitory antibody response in a phase 1a clinical trial. PloS One 2.
174. M. Ozkan Quantum dots and other nanoparticles: what can they offer to drug discovery? Drug Discov. Today 9 2004 1065 1071 (Pubitemid 39593656)
175. B. Ozpolat, A.K. Sood, and G. Lopez-Berestein Nanomedicine based approaches for the delivery of siRNA in cancer J. Internal Med. 267 2010 44 53
176. Palmer, M.; Parker, J.; Modi, S.; Butts, C.; Smylie, M.; Meikle, A.; Kehoe, M.; MacLean, G.; Longenecker, M.; 2001. Phase I study of the BLP25 (MUC1 peptide) liposomal vaccine for active specific immunotherapy in stage IIIB/IV non-small-cell lung cancer. Clin. Lung Cancer 3, 49-57 (discussion 58). (Pubitemid 32904315)
177. D. Papahadjopoulos, T.M. Allen, A. Gabizon, E. Mayhew, K. Matthay, S.K. Huang, K.D. Lee, M.C. Woodle, D.D. Lasic, C. Redemann, and F.J. Martin Sterically stabilized liposomes - improvements in pharmacokinetics and antitumor therapeutic efficacy Proc. Natl. Acad. Sci. U. S. A. 88 1991 11460 11464 (Pubitemid 21916061)
178. P. Parhi, C. Mohanty, and S.K. Sahoo Nanotechnology-based combinational drug delivery: an emerging approach for cancer therapy Drug Discov. Today 17 2012 1044 1052
179. J.W. Park, K. Hong, P. Carter, H. Asgari, L.Y. Guo, G.A. Keller, C. Wirth, R. Shalaby, C. Kotts, and W.I. Wood Development of anti-p185HER2 immunoliposomes for cancer therapy Proc. Natl. Acad. Sci. U S A 92 1995 1327 1331
180. S.B. Park, A.V. Krishnan, C.S.Y. Lin, D. Goldstein, M. Friedlander, and M.C. Kiernan Mechanisms underlying chemotherapy-induced neurotoxicity and the potential for neuroprotective strategies Curr. Med. Chem. 15 2008 3081 3094
181. H.M. Patel Serum opsonins and liposomes - their interaction and opsonophagocytosis Crit. Rev. Ther. Drug 9 1992 39 90
182. H.M. Patel Serum opsonins and liposomes: their interaction and opsonophagocytosis Crit. Rev. Ther. Drug Carrier Syst. 9 1992 39 90
183. D. Peer, J.M. Karp, S. Hong, O.C. FaroKHzad, R. Margalit, and R. Langer Nanocarriers as an emerging platform for cancer therapy Nat. Nanotechnol. 2 2007 751 760 (Pubitemid 350223348)
184. R. Perezsoler Liposomes as carriers of antitumor agents - toward a clinical reality Cancer Treat. Rev. 16 1989 67 82
185. V. Perumal, S. Banerjee, S. Das, R. Sen, and M. Mandal Effect of liposomal celecoxib on proliferation of colon cancer cell and inhibition of DMBA-induced tumor in rat model Cancer Nanotechnol. 2 2011 67 79
186. A.L. Petersen, T. Binderup, R.I. Jolck, P. Rasmussen, J.R. Henriksen, A.K. Pfeifer, A. Kjaer, and T.L. Andresen Positron emission tomography evaluation of somatostatin receptor targeted 64Cu-TATE-liposomes in a human neuroendocrine carcinoma mouse model J. Control. Release 160 2012 254 263
187. C.E. Petre, and D.P. Dittmer Liposomal daunorubicin as treatment for Kaposi's sarcoma Int. J. Nanomed. 2 2007 277 288 (Pubitemid 350047773)
188. R.A. Petros, and J.M. DeSimone Strategies in the design of nanoparticles for therapeutic applications Nat. Rev. Drug. Discov. 9 2010 615 627
189. M.A. Phillips, M.L. Gran, and N.A. Peppas Targeted nanodelivery of drugs and diagnostics Nano Today 5 2010 143 159
190. K.F. Pirollo, L. Xu, and E.H. Chang Non-viral gene delivery for p53 Curr. Opin. Mol. Ther. 2 2000 168 175 (Pubitemid 30212266)
191. A.M. Ponce, B.L. Viglianti, D.H. Yu, P.S. Yarmolenko, C.R. Michelich, J. Woo, M.B. Bally, and M.W. Dewhirst Magnetic resonance imaging of temperature-sensitive liposome release: Drug dose painting and antitumor effects J. Natl. Cancer I 99 2007 53 63
192. A.M. Ponce, Z. Vujaskovic, F. Yuan, D. Needham, and M.W. Dewhirst Hyperthermia mediated liposomal drug delivery Int. J. Hyperther. 22 2006 205 213 (Pubitemid 43878680)
193. R.T.P. Poon, and N. Borys Lyso-thermosensitive liposomal doxorubicin: an adjuvant to increase the cure rate of radiofrequency ablation in liver cancer Future Oncol. 7 2011 937 945
194. N.G. Portney, and M. Ozkan Nano-oncology: drug delivery, imaging, and sensing Anal. Bioanal. Chem. 384 2006 620 630 (Pubitemid 43237915)
195. P. Pradhan, J. Giri, R. Banerjee, J. Bellare, and D. Bahadur Preparation and characterization of manganese ferrite-based magnetic liposomes for hyperthermia treatment of cancer J. Magn. Magn. Mater. 311 2007 208 215 (Pubitemid 46401038)
196. P. Pradhan, J. Giri, F. Rieken, C. Koch, O. Mykhaylyk, M. Doblinger, R. Banerjee, D. Bahadur, and C. Plank Targeted temperature sensitive magnetic liposomes for thermo-chemotherapy J. Control. Release 142 2010 108 121
197. S. Prakash, M. Malhotra, W. Shao, C. Tomaro-Duchesneau, and S. Abbasi Polymeric nanohybrids and functionalized carbon nanotubes as drug delivery carriers for cancer therapy Adv. Drug Deliv. Rev. 63 2011 1340 1351
198. Priebe, W.; Perez-Soler, R.; 1993. Design and tumor targeting of anthracyclines able to overcome multidrug resistance: a double-advantage approach. Pharmacol. Ther. 60, 215-234. (Pubitemid 24117376)
199. Z.M. Qian, H.Y. Li, H.Z. Sun, and K. Ho Targeted drug delivery via the transferrin receptor-mediated endocytosis pathway Pharmacol. Rev. 54 2002 561 587 (Pubitemid 35351196)
200. J.A. Reddy, and P.S. Low Enhanced folate receptor mediated gene therapy using a novel pH-sensitive lipid formulation J. Control. Release 64 2000 27 37 (Pubitemid 30035305)
201. K. Riviere, H.M. Kieler-Ferguson, K. Jerger, and F.C. Szoka Anti-tumor activity of liposome encapsulated fluoroorotic acid as a single agent and in combination with liposome irinotecan J. Control. Release 153 2011 288 296
202. M.A. Rodriguez, R. Pytlik, T. Kozak, M. Chhanabhai, R. Gascoyne, B. Lu, S.R. Deitcher, J.N. Winter, and M. Investigators Vincristine sulfate liposomes injection (Marqibo) in heavily pretreated patients with refractory aggressive non-hodgkin lymphoma report of the pivotal phase 2 study Cancer 115 2009 3475 3482
203. P.G. Rose Pegylated liposomal doxorubicin: optimizing the dosing schedule in ovarian cancer Oncologist 10 2005 205 214 (Pubitemid 40463158)
204. S. Rosentha, and S. Kaufman Vincristine neurotoxicity Ann. Intern. Med. 80 1974 733 737
205. Y.J. Rui, S. Wang, P.S. Low, and D.H. Thompson Diplasmenylcholine-folate liposomes: an efficient vehicle for intracellular drug delivery J. Am. Chem. Soc. 120 1998 11213 11218 (Pubitemid 28531061)
206. A. Samad, Y. Sultana, and M. Aqil Liposomal drug delivery systems: an update review Curr. Drug Deliv. 4 2007 297 305 (Pubitemid 47554274)
207. P. Sapra, and T.M. Allen Ligand-targeted liposomal anticancer drugs Prog. Lipid Res. 42 2003 439 462 (Pubitemid 36700404)
208. D.P. Sarkar, K. Ramani, and S.K. Tyagi Targeted gene delivery by virosomes Methods Mol. Biol. 199 2002 163 173
209. J.M. Saul, A.V. Annapragada, and R.V. Bellamkonda A dual-ligand approach for enhancing targeting selectivity of therapeutic nanocarriers J. Control. Release 114 2006 277 287 (Pubitemid 44310813)
210. R.M. Schiffelers, G.A. Koning, T.L. ten Hagen, M.H. Fens, A.J. Schraa, A.P. Janssen, R.J. Kok, G. Molema, and G. Storm Anti-tumor efficacy of tumor vasculature-targeted liposomal doxorubicin J. Control. Release 91 2003 115 122 (Pubitemid 37288882)
211. J.E. Schroeder, I. Shweky, H. Shmeeda, U. Banin, and A. Gabizon Folate-mediated tumor cell uptake of quantum dots entrapped in lipid nanoparticles J. Control. Release 124 2007 28 34 (Pubitemid 350088213)
212. G. Schuch EndoTAG-1. MediGene Curr. Opin. Investig. Drugs 6 2005 1259 1265
213. S.C. Semple, A. Akinc, J.X. Chen, A.P. Sandhu, B.L. Mui, C.K. Cho, D.W.Y. Sah, D. Stebbing, E.J. Crosley, E. Yaworski, I.M. Hafez, J.R. Dorkin, J. Qin, K. Lam, K.G. Rajeev, K.F. Wong, L.B. Jeffs, L. Nechev, M.L. Eisenhardt, M. Jayaraman, M. Kazem, M.A. Maier, M. Srinivasulu, M.J. Weinstein, Q.M. Chen, R. Alvarez, S.A. Barros, S. De, S.K. Klimuk, T. Borland, V. Kosovrasti, W.L. Cantley, Y.K. Tam, M. Manoharan, M.A. Ciufolini, M.A. Tracy, A. de Fougerolles, I. MacLachlan, P.R. Cullis, T.D. Madden, and M.J. Hope Rational design of cationic lipids for siRNA delivery Nat. Biotechnol. 28 2010 172 176
214. Sessa, G.; Weissman. G, 1968. Phospholipid spherules (liposomes) as a model for biological membranes. J. Lipid Res. 9, 310-318.
215. G.F. Shi, W.J. Guo, S.M. Stephenson, and R.J. Lee Efficient intracellular drug and gene delivery using folate receptor-targeted pH-sensitive liposomes composed of cationic/anionic lipid combinations J. Control. Release 80 2002 309 319 (Pubitemid 34273768)
216. M. Shinkai, M. Yanase, H. Honda, T. Wakabayashi, J. Yoshida, and T. Kobayashi Intracellular hyperthermia for cancer using magnetite cationic liposomes: In vitro study Jpn. J. Cancer Res. 87 1996 1179 1183 (Pubitemid 26420027)
217. C. Smeesters, L. Giroux, B. Vinet, R. Arnoux, P. Chaland, J. Corman, G. Stlouis, and P. Daloze Efficacy of incorporating cyclosporine into liposomes to reduce its nephrotoxicity Can. J. Surg. 31 1988 34 36
218. J.J. Sudimack, W.J. Guo, W. Tjarks, and R.J. Lee A novel pH-sensitive liposome formulation containing oleyl alcohol Bba Biomembr. 1564 2002 31 37 (Pubitemid 34717866)
219. S.S. Suri, H. Fenniri, and B. Singh Nanotechnology-based drug delivery systems J. Occup. Med. Toxicol. 2 2007 16
220. T. Tagami, M.J. Ernsting, and S.D. Li Optimization of a novel and improved thermosensitive liposome formulated with DPPC and a Brij surfactant using a robust in vitro system J. Control. Release 154 2011 290 297
221. K. Takara, H. Hatakeyama, N. Ohga, K. Hida, and H. Harashima Design of a dual-ligand system using a specific ligand and cell penetrating peptide, resulting in a synergistic effect on selectivity and cellular uptake Int. J. Pharm. 396 2010 143 148
222. M. Takeuchi, T. Imada, and S. Shinkai Highly selective and sensitive sugar tweezer' designed from a boronic-acid-appended mu- oxobis[porphinatoiron(III)] J. Am. Chem. Soc. 118 1996 10658 10659 (Pubitemid 26381256)
223. P.G. Tardi, R.C. Gallagher, S. Johnstone, N. Harasym, M. Webb, M.B. Bally, and L.D. Mayer Coencapsulation of irinotecan and floxuridine into low cholesterol-containing liposomes that coordinate drug release in vivo Biochim. Biophys. Acta 1768 2007 678 687 (Pubitemid 46275599)
224. C. Theodossiou, J.A. Cook, J. Fisher, D. Teague, J.E. Liebmann, A. Russo, and J.B. Mitchell Interaction of gemcitabine with paclitaxel and cisplatin in human tumor cell lines Int. J. Oncol. 12 1998 825 832 (Pubitemid 28133574)
225. Thompson, F.M.; Porter, D.W.; Okitsu, S.L.; Westerfeld, N.; Vogel, D.; Todryk, S.; Poulton, I.; Correa, S.; Hutchings, C.; Berthoud, T.; Dunachie, S.; Andrews, L.; Williams, J.L.; Sinden, R.; Gilbert, S.C.; Pluschke, G.; Zurbriggen, R.; Hill, A.V.S.; 2008. Evidence of blood stage efficacy with a virosomal malaria vaccine in a phase IIa clinical trial. PloS One 3.
226. C. Tilcock, E. Unger, P. Cullis, and P. Macdougall Liposomal Gd-Dtpa - preparation and characterization of relaxivity Radiology 171 1989 77 80 (Pubitemid 19093047)
227. V.P. Torchilin Recent advances with liposomes as pharmaceutical carriers Nat. Rev. Drug Discov. 4 2005 145 160 (Pubitemid 40282557)
228. V.P. Torchilin, T.S. Levchenko, K.R. Whiteman, A.A. Yaroslavov, A.M. Tsatsakis, A.K. Rizos, E.V. Michailova, and M.I. Shtilman Amphiphilic poly-N-vinylpyrrolidones: synthesis, properties and liposome surface modification Biomaterials 22 2001 3035 3044 (Pubitemid 32768711)
229. V.P. Torchilin, M.I. Shtilman, V.S. Trubetskoy, K. Whiteman, and A.M. Milstein Amphiphilic vinyl-polymers effectively prolong liposome circulation time in-vivo Bba Biomembr. 1195 1994 181 184 (Pubitemid 24318108)
230. C. Turner, N. Weir, C. Catterall, T.S. Baker, and M.N. Jones The transfection of Jurkat T-leukemic cells by use of pH-sensitive immunoliposomes J. Liposome Res. 12 2002 45 50 (Pubitemid 34846955)
231. J.C. Underwood, and I. Carr The ultrastructure and permeability characteristics of the blood vessels of a transplantable rat sarcoma J. Pathol. 107 1972 157 166
232. B.L. Viglianti, S.A. Abraham, C.R. Michelich, P.S. Yarmolenko, J.R. MacFall, M.B. Bally, and M.W. Dewhirst In vivo monitoring of tissue pharmacokinetics of liposome/drug using MRI: Illustration of targeted delivery Magn. Reson. Med. 51 2004 1153 1162 (Pubitemid 38797000)
233. B.L. Viglianti, A.M. Ponce, C.R. Michelich, D.H. Yu, S.A. Abraham, L. Sanders, P.S. Yarmolenko, T. Schroeder, J.R. MacFall, D.P. Barboriak, O.M. Colvin, M.B. Bally, and M.W. Dewhirst Chemodosimetry of in vivo tumor liposomal drug concentration using MRI Magn. Reson. Med. 56 2006 1011 1018 (Pubitemid 44691343)
234. L.L. Villa, R.L. Costa, C.A. Petta, R.P. Andrade, K.A. Ault, A.R. Giuliano, C.M. Wheeler, L.A. Koutsky, C. Malm, M. Lehtinen, F.E. Skjeldestad, S.E. Olsson, M. Steinwall, D.R. Brown, R.J. Kurman, B.M. Ronnett, M.H. Stoler, A. Ferenczy, D.M. Harper, G.M. Tamms, J. Yu, L. Lupinacci, R. Railkar, F.J. Taddeo, K.U. Jansen, M.T. Esser, H.L. Sings, A.J. Saah, and E. Barr Prophylactic quadrivalent human papillomavirus (types 6, 11, 16, and 18) L1 virus-like particle vaccine in young women: a randomised double-blind placebo-controlled multicentre phase II efficacy trial Lancet Oncol. 6 2005 271 278 (Pubitemid 40590263)
235. J.E. Volanakis, and A.J. Narkates Interaction of C-reactive protein with artificial phosphatidylcholine bilayers and complement J. Immunol. 126 1981 1820 1825 (Pubitemid 11120965)
236. D.D. Vonhoff, M.W. Layard, P. Basa, H.L. Davis, A.L. Vonhoff, M. Rozencweig, and F.M. Muggia Risk-factors for doxorubicin-induced congestive heart-failure Ann. Intern. Med. 91 1979 710 717
237. E. Waelti, N. Wegmann, R. Schwaninger, A. Wetterwald, C. Wingenfeld, B. Rothen-Rutishauser, and C.D. Gimmi Targeting her-2/neu with antirat Neu virosomes for cancer therapy Cancer Res. 62 2002 437 444 (Pubitemid 34106416)
238. A. Wagner, and K. Vorauer-Uhl Liposome technology for industrial purposes J. Drug Deliv. 2011 591325
239. C. Wang, X. Gao, and X.G. Su In vitro and in vivo imaging with quantum dots Anal. Bioanal. Chem. 397 2010 1397 1415
240. C.Y. Wang, and L. Huang pH-sensitive immunoliposomes mediate target-cell-specific delivery and controlled expression of a foreign gene in mouse Proc. Natl. Acad. Sci. U. S. A. 84 1987 7851 7855
241. K.M. Wasan, and M. Kwong Blood and plasma lipoprotein distribution and gender differences in the plasma pharmacokinetics of lipid-associated annamycin Pharmacol. Toxicol. 80 1997 301 307 (Pubitemid 27264825)
242. S.A. Weinzimer, T.B. Gibson, P.F. Collett-Solberg, A. Khare, B.R. Liu, and P. Cohen Transferrin is an insulin-like growth factor-binding protein-3 binding protein J. Clin. Endocr. Metab. 86 2001 1806 1813 (Pubitemid 32374942)
243. R.R. White, B.A. Sullenger, and C.P. Rusconi Developing aptamers into therapeutics J. Clin. Investig. 106 2000 929 934
244. M.C. Woodle, C.M. Engbers, and S. Zalipsky New amphipatic polymer lipid conjugates forming long-circulating reticuloendothelial system-evading liposomes Bioconjug. Chem. 5 1994 493 496
245. Y. Wu, M. Crawford, B. Yu, Y. Mao, S.P. Nana-Sinkam, and L.J. Lee MicroRNA delivery by cationic lipoplexes for lung cancer therapy Mol. Pharma. 8 2011 1381 1389
246. R. Xie, S. Hong, L. Feng, J. Rong, and X. Chen Cell-selective metabolic glycan labeling based on ligand-targeted liposomes J. Am. Chem. Soc. 134 2012 9914 9917
247. X.B. Xiong, Y. Huang, W.L. Lu, X. Zhang, H. Zhang, T. Nagai, and Q. Zhang Intracellular delivery of doxorubicin with RGD-modified sterically stabilized liposomes for an improved antitumor efficacy: In vitro and in vivo J. Pharma. Sci. 94 2005 1782 1793 (Pubitemid 41360872)
248. L. Xu, C.C. Huang, W.Q. Huang, W.H. Tang, A. Rait, Y.Z. Yin, I. Cruz, L.M. Xiang, K.F. Pirollo, and E.H. Chang Systemic tumor-targeted gene delivery by anti-transferrin receptor scFv-immunoliposomes Mol. Cancer Ther. 1 2002 337 346
249. L. Xu, M.F. Wempe, and T.J. Anchordoquy The effect of cholesterol domains on PEGylated liposomal gene delivery in vitro Ther. Deliv. 2 2011 451 460
250. Y. Yamada, Y. Shinohara, T. Kakudo, S. Chaki, S. Futaki, H. Kamiya, and H. Harashima Mitochondrial delivery of mastoparan with transferrin liposornes equipped with a pH-sensitive fusogenic peptide for selective cancer therapy Int. J. Pharm. 303 2005 1 7 (Pubitemid 41318016)
251. M.B. Yatvin, J.N. Weinstein, W.H. Dennis, and R. Blumenthal Design of liposomes for enhanced local release of drugs by hyperthermia Science 202 1978 1290 1293 (Pubitemid 9154441)
252. X. Ying, H. Wen, W.L. Lu, J. Du, J. Guo, W. Tian, Y. Men, Y. Zhang, R.J. Li, T.Y. Yang, D.W. Shang, J.N. Lou, L.R. Zhang, and Q. Zhang Dual-targeting daunorubicin liposomes improve the therapeutic efficacy of brain glioma in animals J. Control. Release 141 2010 183 192
253. S. Zalipsky, N. Mullah, and M. Qazen Preparation of poly(ethylene glycol)-grafted liposomes with ligands at the extremities of polymer chains Method Enzymol. 387 2004 50 69
254. J.Q. Zhang, Z.R. Zhang, H. Yang, Q.Y. Tan, S.R. Qin, and X.L. Qiu Lyophilized paclitaxel magnetoliposomes as a potential drug delivery system for breast carcinoma via parenteral administration: In vitro and in vivo studies Pharm. Res. Dordr. 22 2005 573 583 (Pubitemid 40603255)
255. L. Zhang, F.X. Gu, J.M. Chan, A.Z. Wang, R.S. Langer, and O.C. Farokhzad Nanoparticles in medicine: Therapeutic applications and developments Clin. Pharmacol. Ther. 83 2008 761 769 (Pubitemid 351556021)
256. L.F. Zhang, and S. Granick How to stabilize phospholipid liposomes (using nanoparticles) Nano Lett. 6 2006 694 698
257. Y.X. Zhao, L. Wang, M.N. Yan, Y.L. Ma, G.X. Zang, Z.N. She, and Y.H. Deng Repeated injection of PEGylated solid lipid nanoparticles induces accelerated blood clearance in mice and beagles Int. J. Nanomed. 7 2012 2891 2900